Researchers at Weill Cornell Medicine have discovered that a parasite that causes malaria when transmitted through a mosquito bite can shut down a key set of genes, rendering itself “immunologically invisible” — sometimes for years.
Four leading research institutions, including Weill Cornell Medicine, have united under the Weill Cancer Hub East, an innovative, collaborative partnership that aims to transform cancer treatment.
A new study by researchers at Cornell Tech and the University of Pennsylvania shows freelance writers who are suspected of using AI have worse evaluations and hiring outcomes.
Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the injectable drugs.
Cornell Tech, the groundbreaking campus of Cornell University dedicated to developing leaders and technologies for the AI era, has announced the opening of The Bridge, a new state-of-the-art flexible workspace for entrepreneurs, early and mid-stage ventures, and more established companies.
The Translational Research Institute for Pain in Later Life, a New York City-based center to help older adults prevent and manage pain, has been awarded a five-year, $5 million renewal grant from the National Institute on Aging.
A new analysis finds that Cornell Tech, its alumni and startups achieved $768 million in total economic impact in New York City in the 2023-24 fiscal year. That impact is expected to reach $1.5 billion by 2030.
The modification commonly found on messenger RNAs plays a surprisingly large role in how cells respond to stress, according to a study led by Weill Cornell Medicine investigators.
Teams of health care providers called Accountable Care Organizations participating in the Medicare Shared Savings Program have saved Medicare between $4.1 billion and $8.1 billion from 2012–2019, according to a new study from Weill Cornell Medicine investigators.